These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 15546118

  • 1. Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design.
    Singh N.
    Clin Infect Dis; 2004 Oct 15; 39 Suppl 4():S200-6. PubMed ID: 15546118
    [Abstract] [Full Text] [Related]

  • 2. Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.
    McCoy D, Depestel DD, Carver PL.
    Pharmacotherapy; 2009 Nov 15; 29(11):1306-25. PubMed ID: 19857148
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation.
    Hellinger WC, Bonatti H, Yao JD, Alvarez S, Brumble LM, Keating MR, Mendez JC, Kramer DJ, Dickson RC, Harnois DM, Spivey JR, Hughes CB, Nguyen JH, Steers JL.
    Liver Transpl; 2005 Jun 15; 11(6):656-62. PubMed ID: 15915482
    [Abstract] [Full Text] [Related]

  • 5. Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections.
    Mohammad RA, Klein KC.
    Ann Pharmacother; 2006 Dec 15; 40(12):2148-54. PubMed ID: 17148653
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients.
    Perfect JR, Dodds Ashley E, Drew R.
    Clin Infect Dis; 2004 Oct 15; 39 Suppl 4():S207-10. PubMed ID: 15546119
    [Abstract] [Full Text] [Related]

  • 8. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
    Salavert M.
    Int J Antimicrob Agents; 2008 Nov 15; 32 Suppl 2():S149-53. PubMed ID: 19013340
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antifungal prophylaxis in liver transplant recipients.
    Eschenauer GA, Lam SW, Carver PL.
    Liver Transpl; 2009 Aug 15; 15(8):842-58. PubMed ID: 19642130
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combination therapeutic approaches for the management of invasive aspergillosis in organ transplant recipients.
    Singh N, Pursell KJ.
    Mycoses; 2008 Mar 15; 51(2):99-108. PubMed ID: 18254745
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.